TM4SF18 is implicated in gastric cancer (GC) progression:
Overexpression: Elevated in GC tissues vs. adjacent normal tissues, correlating with poor differentiation, lymph node metastasis, and advanced TNM stages .
Functional Impact: Knockdown reduces GC cell proliferation, migration, invasion, and EMT markers (e.g., reduced N-cadherin, vimentin) .
Prognostic Value: High expression predicts poor survival (Kaplan-Meier analysis) .
ROC Analysis: TM4SF18 shows diagnostic accuracy for GC (AUC = 0.786) .
Biomarker Utility: Dynamic monitoring of TM4SF18 levels may aid in prognosis and treatment monitoring .
TM4SF18 inversely correlates with immune cell markers (e.g., CD8+ T cells, macrophages) and pathways (e.g., IFN-γ), suggesting it suppresses antitumor immunity . This association may explain reduced responses to immune checkpoint inhibitors in TM4SF18-high tumors .